pocketful logo light
pocketful logo light
Cipla Ltd logo

Cipla Ltd

NSE: CIPLA BSE: 500087

₹1366

(0.53%)

Tue, 15 Sept 2026, 02:14 pm

mtf coin illustrationMTF 5x

Cipla Share Price Live Chart

1 Day

(0.53%)

No Result Found

Summary

  • Market Cap (in Cr)

    112970.91

  • Net Profit (in Cr)

    5291.05

  • P/B

    3.73

  • Sector P/E

    33.76

  • P/E

    22.08

  • EV/EBITDA

    14.53

  • Debt/Equity (Industry)

    0.16

  • Interest Cover (Industry)

    17.01

  • ROCE (Industry)

    16.41

  • RONW (Industry)

    14.52

  • ROE

    18.28

  • ROCE

    23.15

  • Debt/Equity

    0.02

  • EPS (TTM)

    50.50

  • Dividend Yield

    0.93

  • Book Value

    426.24

  • Interest Cover

    111

Analysis

No Result Found

Read More

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersMAR 2026DEC 2025SEPT 2025JUN 2025MAR 2025
Promoters29.2129.2129.2129.1929.20
FII22.5523.9324.5425.2426.28
DII31.9730.7230.2529.2628.15
Public16.2616.1315.9916.3016.37
Government0.000.000.000.000.00

Read More

Technical Analysis

RSI

32.08

MACD

-19.91

50 DMA

1428.61

200 DMA

1388.92

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic1606.801519.801464.501432.801377.501345.801258.80
Fibonacci1519.801486.571466.031432.801399.571379.031345.80
Camarilla1433.131425.151417.171432.801401.231393.251385.28

Pivots Level: Classic

R3

+174

1606.80

R2

+87

1519.80

R1

+31.70

1464.50

1432.80
1432.80
Pivot Point
LTP: 1351

S1

-55.30

1377.50

S2

-87

1345.80

S3

-174

1258.80

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    1380.88

  • 20-EMA

    1398.80

  • 30-EMA

    1408.19

  • 50-EMA

    1412.85

  • 100-EMA

    1406.04

  • 200-EMA

    1410.40

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
13 May 2026dividend₹13.00 Dividend /Share05 Jun 2026
13 May 2026agm
13 May 2026board-meetingsAccounts, Quarterly Results, Final Dividend
23 Jan 2026board-meetingsQuarterly Results
30 Oct 2025board-meetingsQuarterly Results
27 May 2025dividendFinal Dividend - Rs. - 1327 Jun 2025
13 May 2025agm
13 May 2025dividend₹13.00 Dividend /Share27 Jun 2025
02 Jul 2024dividendFinal Dividend - Rs. - 1302 Aug 2024
10 May 2024dividend₹13.00 Dividend /Share02 Aug 2024

Read More

Peer Comparison

Cipla Ltd logo

Cipla Ltd

Divis Laboratories Ltd logo

Divis Laboratories Ltd

Sun Pharmaceutical Industries Ltd logo

Sun Pharmaceutical Industries Ltd

Dr Reddys Laboratories Ltd logo

Dr Reddys Laboratories Ltd

Torrent Pharmaceuticals Ltd logo

Torrent Pharmaceuticals Ltd

Zydus Lifesciences Ltd logo

Zydus Lifesciences Ltd

Read More

Cipla Ltd About

Cipla is in the business of manufacturing, developing, and marketing wide range of branded and generic formulations and Active Pharmaceutical Ingredients (APIs). The Company has its wide network of manufacturing, trading and other incidental operations in India and International markets.

Industry

Pharmaceuticals - Indian - Bulk Drugs & Formln

Founded

1935

Headquarters

CEO

Y K Hamied

Employees

Contact

Website icon

Website

http://www.cipla.com

Email icon

Email

cosecretary@cipla.com, contactus@cipla.com

Phone icon

Phone

91-22-24826000

Location icon

Location

Cipla House Peninsula Buss Par, Ganpatrao Kadam Mg Lower Parel, Mumbai, Maharashtra, 400013

Read More

Cipla Ltd Company History

YearHistory
2020
  • Completed phase-3 clinical study of generic asthma drug.
  • Inked licensing pact with Gilead Sciences for potential COVID-19 treatment drug.
  • Launched generic remdesivir for coronavirus patients.
  • Collaborated with Stempeutics to launch Stempeucel for CLI treatment in India.
  • Launched antibody detection kit for COVID-19 in India.
  • Conferred Golden Peacock Global Award for Excellence in Corporate Governance 2020.
2021
  • Set up 30 MW solar plant in Maharashtra.
  • Partnered with Alvotech to market biosimilars in Australia and New Zealand.
  • Bagged National Energy Conservation Award 2021 in drug and pharmaceutical sector.
  • Won Gold for Remdesivir in Covid Care Brand Category.
2022
  • Launched leuprolide acetate injection depot (22.5mg).
  • Received USFDA approval for generic Revlimid (Lenalidomide Capsules).
  • Launched child-friendly 4-in-1 antiretroviral treatment for HIV with DNDi in South Africa.
  • Scored highest among pharma companies in CRISIL Sustainability Rating 2022.
  • Won Frost & Sullivan and TERI Sustainability 4.0 Award.
2023
  • Acquired additional stake in GoApptiv Private Limited.
  • Announced acquisition of South Africa-based Actor Pharma.
2024
  • Acquired additional shares in Achira Labs Private Limited.
  • Merged Cipla Technologies LLC, USA with Cipla USA Inc.
  • Announced joint venture in the US with Kemwell Biopharma and Manipal Education & Medical Group for cell therapy products.

Read More

Deals

Client NameDeal TypeOrder SideQTYAvg PriceDate
GOLDMAN SACHS (SINGAPORE) PTE.- ODIblockSell91604156516 Oct 2025
GOLDMAN SACHS BANK EUROPESE - ODIblockBuy91604156516 Oct 2025
THE MTBJ LTD.AS TRST FOR GOVERNMENT PENSION INVESTMENT FUND MTBJ400045849blockBuy156532148514 Jul 2025
THE MTBJ LTD. AS TRST FOR GOVRNMNT PENSION INVSTMNT FUND MTBJ400045828blockSell156532148514 Jul 2025
SAMINA HAMIEDbulkSell89547501518.7502 Dec 2024
RUMANA HAMIEDbulkSell49432501518.7502 Dec 2024
SAMINA HAMIEDbulkSell8954750134515 May 2024
ICICI PRUDENTIAL MUTUAL FUNDbulkBuy5525999134515 May 2024
SHIRIN HAMIEDbulkSell6363000134515 May 2024
RUMANA HAMIEDbulkSell4943250134515 May 2024

Read More

Cipla Ltd News

Macquarie keeps Cipla at Outperform, target ₹1,675

Macquarie maintains an Outperform rating on Cipla with a target price of ₹1,675, noting key prior observations at the Pithampur plant appear addressed, though five repeat observations remain.

11 Sept 2026

companies

Cipla Gets US FDA Nod for Generic Advair Diskus

Cipla receives US FDA approval for Generic Advair Diskus (fluticasone propionate and salmeterol inhalation powder) in all three strengths, targeting a ~$908 million US market.

27 Jul 2026

companies

Nomura, Citi & JPM Maintain Bullish Stance on Cipla

Nomura, Citi, and JPMorgan maintain Buy/Overweight on Cipla with targets of ₹1,510, ₹1,700, and ₹1,600 respectively, citing retained FY27 margin guidance and strong US pipeline.

24 Jul 2026

investment-ideas

Cipla Posts Record Q1 FY27 Revenue of INR 7,100 Crore

Cipla reports record Q1 FY27 revenue of INR 7,100 crore, targets $1 billion North America run rate by FY27, and maintains EBITDA margin guidance of 18.5%–20%.

24 Jul 2026

companies

Cipla posts Q1FY27 earnings call recording

Cipla Limited has made the audio recording of its Q1FY27 earnings conference call available on its website, as disclosed to stock exchanges.

23 Jul 2026

companies

Read More

Frequently Asked Questions

  • 1.What is the stock price of Cipla Ltd?

    As of 15/09/2026 at 7:44 PM, Cipla Ltd shares are trading at ₹1366.

  • 2.What is the market cap. of Cipla Ltd?

    As of 15/09/2026, the market capitalization of Cipla Ltd is ₹1,10,272.68 crore.

  • 3.When was Cipla Ltd founded?

    Cipla Ltd was founded in 1935.

  • 4.What are the P/E and P/B ratios of Cipla Ltd?

    As of 15/09/2026, Cipla Ltd has a P/E ratio of 32.76 and a P/B ratio of 3.73.

  • 5.How can I buy shares of Cipla Ltd?

    You can buy shares of Cipla Ltd through Pocketful. Simply open a Demat account, complete your KYC, add funds, and place a buy order.

  • 6.What is the shareholding pattern of Cipla Ltd?

    As of March,2026, promoters hold 29.21% in Cipla Ltd, while FIIs, DIIs and public shareholders hold 22.55%, 31.97% and 16.26%, respectively. The government holds 0.00%.

  • 7.Does Cipla Ltd pay dividends?

    Yes, Cipla Ltd pays dividends to eligible shareholders. The latest dividend announced by the company was ₹₹13.00 Dividend /Share per share.

  • 8.What is the dividend yield of Cipla Ltd?

    As of 15 September, 2026, the dividend yield of Cipla Ltd stands at 0.95%.

  • 9.What are the latest financial results of Cipla Ltd?

    For January,2024, Cipla Ltd reported revenue of ₹27,454.00 crore and a net profit of ₹5,273.00 crore.

  • 10.What is the Stock symbol of Cipla Ltd?

    CIPLA is the stock symbol of Cipla Ltd.

  • 11.Who is the CEO of Cipla Ltd?

    The CEO of Cipla Ltd is Y K Hamied.

Open Your Free Demat Account

Enter your phone number